The British National Health System has denied a cancer patient the right to pay for her own medication with her own money, spurring a debate there over what sorts of rights individuals have to pay for their own treatment. The 58 year-old breast cancer patient, Collette Mills, had been receiving treatment under England's state-sponsored system, but decided to pay for the drug Avastin-which is not covered by the NHS but which has been shown to improve outcomes for cancer patients-out-of-pocket.
Under the rules of the system, if she had paid for Avastin herself, she would have had to pay all costs associated with her cancer treatment, regardless of whether or not they would ordinarily be covered by the NHS. The government has defended its actions by saying that allowing people to use their own money to supplement state-sponsored treatment would create a "two-tiered system" for the rich and poor.
The case mirrors a case of a separate woman, Debbie Hirst, who also tried, unsuccessfully, to pay for Avastin with her own money to treat her cancer. The New York Times notes that Hirst's cancer has progressed, and in "a final irony Mrs. Hirst was told early this month that her cancer had spread and that her condition had deteriorated so much that she could have the Avastin after all – paid for by the health service."